Results 71 to 80 of about 10,843 (238)

Lentigo maligna mimicking invasive melanoma in Mohs surgery: a case report [v1; ref status: indexed, http://f1000r.es/2mp]

open access: yesF1000Research, 2014
Lentigo maligna is a lentiginous proliferation of atypical melanocytes confined to the epidermis, typically on chronically sun-damaged skin. Following biopsy and exclusion of invasive disease, therapy may involve Mohs surgery, topical treatment or ...
Teresa Tsakok   +4 more
doaj   +1 more source

Lentigo maligna and radiotherapy. [PDF]

open access: yes, 2000
The first part of the paper is devoted to a transient analysis of traffic generated by bursty sources. These sources are governed by a modulating process, whose state determines the traffic rate at which the source transmits.
Mandjes, M.R.H., van Uitert, M.J.G.
core   +3 more sources

Outdoor work as risk factor for facial melanoma: UV exposure, risk awareness, and occupational relevance

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background This study explored UV exposure and prevention behaviors among melanoma patients, focusing on occupational UV exposure, melanoma characteristics, risk awareness, and protective behaviors. Patients and Methods This cross‐sectional study analyzed demographics, melanoma characteristics, UV exposure, awareness, and preventive measures ...
Susanne Dugas‐Breit   +3 more
wiley   +1 more source

Melanoma maligno: Diagnóstico clínico x histopatológico nas especialidades médicas. [PDF]

open access: yes, 1998
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Cirúrgica, Curso de Medicina, Florianópolis ...
Soares, Claúdia Bernadet
core  

Dermatological Malignancies at a University Teaching Hospital in north-western Tanzania: A Retrospective Review of 154 Cases [PDF]

open access: yes, 2012
Dermatological malignancies are among the most common form of cancers and the global incidence has been increasing at an alarming rate. A retrospective study was conducted to determine the prevalence, histopathological pattern, anatomical distribution ...
Chalya, Phillipo L.   +6 more
core   +2 more sources

Topical Imiquimod Treatment of Lentigo Maligna

open access: yesCase Reports in Dermatology, 2009
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasive melanoma if left untreated. It mainly occurs on sun-exposed areas of elderly patients.
F. Ventura   +4 more
doaj   +1 more source

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. [PDF]

open access: yes, 2016
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and safety of vismodegib in these patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC) in the ERIVANCE BCC
Arron, Sarah   +8 more
core   +2 more sources

Differentiating solar lentigines from post‐inflammatory hyperpigmentation with hyperspectral imaging: A pilot study

open access: yesInternational Journal of Cosmetic Science, EarlyView.
This preliminary study attempted to characterize solar lentigines and post‐inflammatory hyperpigmentation (PIH) observed on Japanese women. Colorimetric features and chromophore concentrations were measured using hyperspectral imaging for each hyperpigmentation type.
Victor Egana   +4 more
wiley   +1 more source

Atypical Presentation and Course of ACTH-Independent Cushing’s Syndrome in Two Families

open access: yesJCRPE
Primary pigmented nodular adrenocortical disease (PPNAD) is a rare genetic disease mainly associated with Carney complex (CNC), which is caused by germline mutations of the regulatory subunit type I-alpha of the cAMP-dependent protein kinase (PRKAR1A ...
Kübra Yüksek Acınıklı   +14 more
doaj   +1 more source

Immune thrombocytopenic purpura: A rare side effect in a patient treated with Imiquimod for lentigo maligna

open access: yesJPRAS Open, 2017
Topical Imiquimod is increasingly used in the treatment of lentigo maligna (LM) for patients not suitable or willing for surgery. It acts as an immune response modifier and is recommended for use with caution in patients with autoimmune disorders.
E.A. Whatling   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy